Olink Holding AB (OLK)
22.99
+0.32
(+1.41%)
USD |
NASDAQ |
May 02, 16:00
22.99
0.00 (0.00%)
After-Hours: 18:05
Olink Debt to Equity Ratio: 0.00 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.0175 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.0217 |
| Date | Value |
|---|---|
| March 31, 2022 | 0.016 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.0165 |
| June 30, 2021 | 0.0087 |
| March 31, 2021 | 0.0081 |
| December 31, 2020 | 0.2058 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Dec 2021
0.2058
Maximum
Dec 2020
0.0226
Average
0.0081
Median
Mar 2021
Debt to Equity Ratio Benchmarks
| Thermo Fisher Scientific Inc | 0.7825 |
| Abliva AB | 0.00 |
| Karolinska Development AB | 0.00 |
| Calliditas Therapeutics AB | 2.806 |
| Oncopeptides AB | 0.8095 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 602.25M |
| Total Liabilities (Quarterly) | 99.55M |
| Shareholders Equity (Quarterly) | 502.70M |
| Current Ratio | 4.748 |